AstraZeneca, Teva Patent Spat Flares Up
The stakes of a patent infringement suit between AstraZeneca PLC and Teva Pharmaceuticals Ltd. over the generic version of AstraZeneca's asthma medication Pulmicort Respules have reached a new level after Teva...To view the full article, register now.
Already a subscriber? Click here to view full article